Prenatal Testing and Prediction of Adverse Perinatal Outcomes
Submission Deadline: 30 Apr 2026
Guest Editor
Special Issue Information
Dear Colleagues,
This Special Issue, Prenatal Testing and Prediction of Adverse Perinatal Outcomes, aims to highlight recent advances in the early identification of pregnancies at risk for complications such as preeclampsia, fetal growth restriction, preterm birth, and stillbirth. The field of prenatal medicine is undergoing a rapid transformation with the integration of innovative approaches including advanced ultrasound imaging, maternal serum and placental biomarkers, non-invasive prenatal testing, and artificial intelligence–based risk stratification tools. Contributions are invited that explore novel diagnostic strategies, predictive modeling, cost-effectiveness analyses, and the real-world implementation of screening and preventive interventions, an example being aspirin prophylaxis. Both original research articles and comprehensive reviews are welcome. By bringing together diverse perspectives, this Special Issue seeks to provide clinicians, researchers, and policymakers with evidence to refine prenatal screening strategies and improve overall perinatal outcomes.
Dr. Dominique A. Badr
Guest Editor
Keywords
- prenatal screening
- first-trimester screening
- non-invasive prenatal testing (NIPT)
- ultrasound biomarkers
- maternal serum biomarkers
- placental growth factor (PlGF)
- preeclampsia prediction
- fetal growth restriction (FGR)
- stillbirth
- adverse perinatal outcomes
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Paper (1)
Clin. Exp. Obstet. Gynecol. 2026, 53(5), 48777; https://doi.org/10.31083/CEOG48777 (registering DOI)
(This article belongs to the Special Issue Prenatal Testing and Prediction of Adverse Perinatal Outcomes)

